One significant advantage of RNA vaccines is their rapid development and production. Because they are based on genetic sequences, they can be designed and manufactured quickly once the genetic information of the virus is known. Additionally, RNA vaccines do not use live virus components, which means there is no risk of causing disease in the vaccinated individual. They also have the potential for strong and long-lasting immunity with fewer doses.
